Ondine Biomedical Statistics

Total Valuation

AIM:OBI has a market cap or net worth of GBP 46.56 million. The enterprise value is 41.23 million.

Market Cap	46.56M
Enterprise Value	41.23M

Important Dates

The next estimated earnings date is Thursday, September 25, 2025.

Earnings Date	Sep 25, 2025
Ex-Dividend Date	n/a

Share Statistics

AIM:OBI has 443.43 million shares outstanding. The number of shares has increased by 39.31% in one year.

Current Share Class	443.43M
Shares Outstanding	443.43M
Shares Change (YoY)	+39.31%
Shares Change (QoQ)	+27.44%
Owned by Insiders (%)	36.41%
Owned by Institutions (%)	22.58%
Float	281.97M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	40.93
PB Ratio	12.20
P/TBV Ratio	12.20
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-3.89
EV / Sales	36.25
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-4.79

Financial Position

The company has a current ratio of 2.05, with a Debt / Equity ratio of 0.02.

Current Ratio	2.05
Quick Ratio	1.73
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	-0.01
Interest Coverage	-670.50

Financial Efficiency

Return on equity (ROE) is -426.20% and return on invested capital (ROIC) is -251.32%.

Return on Equity (ROE)	-426.20%
Return on Assets (ROA)	-130.98%
Return on Invested Capital (ROIC)	-251.32%
Return on Capital Employed (ROCE)	-282.74%
Revenue Per Employee	63,194
Profits Per Employee	-589,013
Employee Count	18
Asset Turnover	0.22
Inventory Turnover	0.62

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +40.00% in the last 52 weeks. The beta is 0.12, so AIM:OBI's price volatility has been lower than the market average.

Beta (5Y)	0.12
52-Week Price Change	+40.00%
50-Day Moving Average	9.07
200-Day Moving Average	8.93
Relative Strength Index (RSI)	77.84
Average Volume (20 Days)	128,067

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, AIM:OBI had revenue of GBP 1.14 million and -10.60 million in losses. Loss per share was -0.04.

Revenue	1.14M
Gross Profit	733,351
Operating Income	-10.79M
Pretax Income	-10.60M
Net Income	-10.60M
EBITDA	-10.68M
EBIT	-10.79M
Loss Per Share	-0.04

Full Income Statement

Balance Sheet

The company has 5.42 million in cash and 93,265 in debt, giving a net cash position of 5.33 million or 0.01 per share.

Cash & Cash Equivalents	5.42M
Total Debt	93,265
Net Cash	5.33M
Net Cash Per Share	0.01
Equity (Book Value)	3.82M
Book Value Per Share	0.01
Working Capital	3.47M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -8.60 million and capital expenditures -5,551, giving a free cash flow of -8.60 million.

Operating Cash Flow	-8.60M
Capital Expenditures	-5,551
Free Cash Flow	-8.60M
FCF Per Share	-0.02

Full Cash Flow Statement

Margins

Gross Margin	64.47%
Operating Margin	-948.95%
Pretax Margin	-932.06%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

AIM:OBI does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-39.31%
Shareholder Yield	n/a
Earnings Yield	-22.77%
FCF Yield	-18.48%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

AIM:OBI has an Altman Z-Score of -31.46 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-31.46
Piotroski F-Score	4